Почетна › Рак на ендометриумот › Пенсилванија
Клинички испитувања за Рак на ендометриумот во Пенсилванија
42 студии за Рак на ендометриумот бараат учесници на локации во Пенсилванија.
Градови во Пенсилванија
Официјален текст на студијата (англиски)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- UPMC Hillman Cancer Center Erie, Erie
- UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg
- Penn State Milton S Hershey Medical Center, Hershey
- и уште 7
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 5.10.2026 · NCT07198074Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Lehigh Valley Hospital-Cedar Crest, Allentown
- UPMC Altoona, Altoona
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- и уште 18
Се регрутираФаза 2
Сите возрасти · Сите полови · Ажурирано 5.10.2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750A Phase 1 Study of the Safety and Tolerability of CTX-10726
- UPMC Hillman Cancer Center, Pittsburgh
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07419841Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
- NRG Oncology, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Се регрутираФаза 1
Возраст 18 и постари · Жени · Ажурирано 2.10.2026 · NCT05950464Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- IRMC Cancer Center, Indiana
- UPMC Hillman Cancer Center - New Castle, New Castle
- и уште 2
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07059884A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Се регрутираФаза 1
Возраст 19 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06586957Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Philadelphia
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT05867251Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- UPMC-Heritage Valley Health System Beaver, Beaver
- UPMC Hillman Cancer Center at Butler Health System, Butler
- UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township
- и уште 22
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 28.9.2026 · NCT05112601DESTINY-PANTUMOUR04
- Research Site, Philadelphia
Се регрутираНабљудувачка студија
Возраст од 18 до 130 · Сите полови · Ажурирано 25.9.2026 · NCT07124000Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Philadelphia
- Research Site, Pittsburgh
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06218914Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Penn State Milton S Hershey Medical Center, Hershey
- Paoli Memorial Hospital, Paoli
- Thomas Jefferson University, Philadelphia
- и уште 2
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 24.9.2026 · NCT05640999A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
Се регрутираФаза 1/2
Возраст 18 и постари · Жени · Ажурирано 24.9.2026 · NCT04590326A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- University of Pittsburgh Medical Center, Pittsburgh
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07114601Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Allegheny Health Network, Pittsburgh
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- St. Luke's University Health Network ( Site 6041), Bethlehem
- Hospital of the University of Pennsylvania ( Site 5007), Philadelphia
- AHN West Penn Hospital ( Site 6006), Pittsburgh
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 17.9.2026 · NCT06952504PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
- Lancaster General Health - Ann B. Barshinger Cancer Institute, Lancaster
- University of Pennsylvania, Philadelphia
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 17.9.2026 · NCT05758688ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT05059444A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Pittsburgh
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT05123482DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Philadelphia
- Research Site, Pittsburgh
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 3.9.2026 · NCT06989112FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT07216105Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- UPMC Hillman Cancer Center, Pittsburgh
Се регрутираФаза 1
Возраст 15 и постари · Сите полови · Ажурирано 25.8.2026 · NCT06276491Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Се регрутираФаза 1/2
12 Months – 30 Years · Сите полови · Ажурирано 25.8.2026 · NCT04851119A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- West Penn Hospital, Pittsburgh
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 21.8.2026 · NCT05548296A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
- UPMC, Pittsburgh
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 21.8.2026 · NCT06774963A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 19.8.2026 · NCT04104776A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT07470853A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT07182149FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05919264Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- Lehigh Valley Health Network, Allentown
Се регрутираНабљудувачка студија
Возраст 18 и постари · Жени · Ажурирано 7.8.2026 · NCT04291612Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Alliance Cancer Specialist, Doylestown
- Allegheny Health Network, Pittsburgh
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 4.8.2026 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT04657068Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Bethlehem
- Research Site, Hershey
- Research Site, Lancaster
- и уште 5
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 29.7.2026 · NCT07044336Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 127, Pittsburgh
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 16.7.2026 · NCT06906341A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Sidney Kimmel Cancer Center, Philadelphia
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT07458347A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- West Penn Allegheny Health, Pittsburgh
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 2.6.2026 · NCT06730347A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 27.3.2026 · NCT06395519Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- Alliance Cancer Specialists, PC, Doylestown
- West Penn Hospital, Pittsburgh
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 24.12.2025 · NCT06463028CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
- Abramson Cancer Center at Penn Medicine, Philadelphia
- University of Pennsylvania Gynecologic Oncology Department, Philadelphia
Се регрутираРана фаза 1
Возраст 18 и постари · Жени · Ажурирано 12.12.2025 · NCT07278986A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
- Allegheny Health, Pittsburgh
Се регрутираФаза 2
Возраст од 18 до 70 · Жени · Ажурирано 30.10.2025 · NCT06481592Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.